… These data can be compared with ongoing anti-PD-1 combination … inevitably heralds frank
hematologic relapse without additional … Clinical significance of minimal residual disease …

… might be loss of cytogenetic or haematological remission, as has … , an ongoing low risk of
molecular relapse exists 56 — the … in which loss of undetectable minimal residual disease is the …

… presence of residual LSCs following remission increases the … clone with EVI1 upregulation
is persistent in BM follow-up [… different molecular characteristic of AML, but every molecular …

… A 30-year-old woman was admitted to the hematology clinic … We continued to monitor
MRD with MFC. The MRD levels in … In summary, considering the late molecular relapse in our …

… CMR continued dasatinib until progression or minimal residual … a hematologic relapse,
one experienced a molecular … remissions and long-term survival can be achieved with a …

… discuss ongoing … complete hematologic response, residual leukemic cells can be evaluated
by reliable techniques in routine practice including conventional cytogenetics and molecular …

… For as long as hematologists and oncologists have been utilizing … Molecular MRD testing
has since evolved to employ highly … There are ongoing efforts in collaboration with regulatory …

… In the meantime, to ensure continued support, we are … Cytogenetic abnormalities were not
associated with positive EOI … a MRD-negative complete remission. Analysis of clinical features …

… count on day 8, remission evaluation of bone marrow on … , and continuous measurements
as mean, minimum-maximum, … MRD analysis and cytogenetic and molecular profiling of the …

… -based threshold that defines complete remission (CR). The … cytogenetics, histopathology,
and molecular genetics, and … the Kruskal-Wallis test for continuous variables, and Pearson's chi…